Vilya raises $21M in Series A extension; Shionogi to build research center in San Diego

Plus, news about Immutep, Eisai and Iterum Therapeutics:

Computational biotech extends Series A: Vilya Therapeutics, a startup based in Seattle,

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Pharmalittle: State Medicaid programs seek discounts for Wegovy; congressional PBM bills work around the fringes

Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot

July 26, 2023

Startup Hims has long-term plans for custom weight loss shots

Digital health company Hims & Hers plans to offer custom versions of wildly popular weight loss shots even after supply shortages resolve, according to an

May 25, 2024

Coya Therapeutics expands COYA 301 patent estate

The deal grants Coya Therapeutics exclusive patent rights and IP rights related to COYA 301 and combinations to treat Parkinson’s disease. Credit: Kateryna Kon via

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.